Pembentukan Kokristal Sebagai Upaya Peningkatan Kelarutan dan Laju Disolusi Obat BCS Kelas II
DOI:
https://doi.org/10.29313/bcsp.v3i2.7497Keywords:
Kokristal, Koformer, Kelarutan, Laju DisolusiAbstract
Solubility is one of the critical physicochemical properties in drug absorption. Co-crystallization is an effort to increase the solubility and dissolution rate of active pharmaceutical ingredients with low solubility. This review article was prepared using the literature study method using literature in the form of scientific articles discussing the definition of cocrystals, cocrystal preparation methods, cocrystal characterization, and the effect of cocrystal formation on the solubility and dissolution rate of a BAF. Based on the study, cocrystal production methods can be divided into solvent-based and grinding. The cocrystallized solid must be characterized to ensure the formation of cocrystals using thermal analysis methods, powder X-ray diffractometry analysis, infrared spectrophotometry, and morphological analysis by microscopy. Cocrystal formation has increased the solubility and dissolution rate of Glimepiride, Pyrimethamine, Trimethoprim, and Meloxicam compared to their pure forms.
Kelarutan merupakan salah satu sifat fisikokimia yang penting dalam absorpsi obat. Kokristalisasi merupakan salah satu upaya peningkatan kelarutan dan laju disolusi bahan aktif farmasi yang memiliki kelarutan rendah. Artikel tinjauan ini dibuat dengan metode studi literatur menggunakan pustaka berupa artikel ilmiah yang membahas definisi kokristal, metode pembuatan kokristal, karakterisasi kokristal, dan pengaruh pembentukan kokristal terhadap kelarutan dan laju disolusi suatu BAF. Berdasarkan hasil kajian metode pembuatan kokristal dapat dibagi menjadi solvent-based dan grinding. Padatan hasil kokristalisasi harus dikarakterisasi untuk memastikan terbentuknya kokristal menggunakan metode analisis termal, analisis difraktometri sinar-X serbuk, spektrofotometri inframerah dan analisis morfologi dengan mikroskopi. Pembentukan kokristal telah meningkatkan kelarutan dan laju disolusi dari Glimepirid, Pirimetamin, Trimetoprim, dan Meloksikam dibandingkan dengan bentuk murninya.
References
[2] K. Jo et al., “Enhancement of aqueous solubility and dissolution of celecoxib through phosphatidylcholine-based dispersion systems solidified with adsorbent carriers,” Pharmaceutics, vol. 11, no. 1, Jan. 2019, doi: 10.3390/pharmaceutics11010001.
[3] Z. Liang, H. Chen, C. Wang, and C. C. Sun, “Discovery, characterization, and pharmaceutical applications of two loratadine–oxalic acid cocrystals,” Crystals (Basel), vol. 10, no. 11, pp. 1–15, Nov. 2020, doi: 10.3390/cryst10110996.
[4] G. Hou et al., “High-temperature stable plasmonic and cavity resonances in metal nanoparticle-decorated silicon nanopillars for strong broadband absorption in photothermal applications,” Nanoscale, vol. 11, no. 31, pp. 14777–14784, Aug. 2019, doi: 10.1039/c9nr05019a.
[5] I. M. Tănase et al., “Physicochemical characterization and molecular modeling study of host–guest systems of aripiprazole and functionalized cyclodextrins,” J Therm Anal Calorim, vol. 141, no. 3, pp. 1027–1039, Aug. 2020, doi: 10.1007/s10973-020-09549-3.
[6] S. Chaudhari, S. A. Nikam, N. Khatri, and S. Wakde, “CO-CRYSTALS: A REVIEW,” Journal of Drug Delivery and Therapeutics, vol. 8, no. 6-s, pp. 350–358, Dec. 2018, doi: 10.22270/jddt.v8i6-s.2194.
[7] D. D. Bavishi and C. H. Borkhataria, “Spring and parachute: How cocrystals enhance solubility,” Progress in Crystal Growth and Characterization of Materials, vol. 62, no. 3. Elsevier Ltd, pp. 1–8, Sep. 01, 2016. doi: 10.1016/j.pcrysgrow.2016.07.001.
[8] S. Kumar and A. Nanda, “Pharmaceutical cocrystals: An overview,” Indian Journal of Pharmaceutical Sciences, vol. 79, no. 6. OMICS International, pp. 858–871, Nov. 01, 2017. doi: 10.4172/pharmaceutical-sciences.1000302.
[9] G. Kuminek, F. Cao, A. Bahia de Oliveira da Rocha, S. Gonçalves Cardoso, and N. Rodríguez-Hornedo, “Cocrystals to facilitate delivery of poorly soluble compounds beyond-rule-of-5,” Advanced Drug Delivery Reviews, vol. 101. Elsevier B.V., pp. 143–166, Jun. 01, 2016. doi: 10.1016/j.addr.2016.04.022.
[10] E. Zaini, A. Halim, S. N. Soewandhi, and D. Setyawan, “Peningkatan Laju Pelarutan Trimetoprim Melalui Metode Ko-kristalisasi dengan Nikotinamida,” 2011. [Online]. Available: https://www.researchgate.net/publication/260480683
[11] Y. A. Najih, B. Widjaja, D. N. Rakhma, and A. Satrio, “Uji Disolusi Kokristal Meloksikam dan Asam Malonat Sebagai Koformer Dibuat dengan Metode Slurry,” Journal of Pharmaceutical Care Anwar Medika, vol. 5, no. 1, pp. 25–36, 2022.
[12] E. Zaini, Y. C. Sumirtapura, S. N. Soewandhi, A. Halim, H. Uekusa, and K. Fujii, “Cocrystalline Phase Transformation of Binary Mixture of Trimethoprim and Sulfamethoxazole by Slurry Technique,” 2014. [Online]. Available: https://www.researchgate.net/publication/266208439
[13] M. Sevukarajan, B. Thanuja, R. Sodanapalli, and R. Nair, “Synthesis and Characterization of a Pharmaceutical Co-Crystal: (Aceclofenac: Nicotinamide),” Tirupati, 2011.
[14] R. Putri Peratiwi, F. Alatas, F. Wahyuni, R. Sugandi, H. Ratih, and F. Hermanto, “PENGARUH PEMBENTUKAN KO-KRISTAL PIRIMETAMIN-ASAM FUMARAT TERHADAP KELARUTAN DAN LAJU DISOLUSINYA,” Kartika-Jurnal Ilmiah Farmasi, vol. 4, no. 1, pp. 31–36, 2016.
[15] X. Liu, M. Lu, Z. Guo, L. Huang, X. Feng, and C. Wu, “Improving the chemical stability of amorphous solid dispersion with cocrystal technique by hot melt extrusion.,” Pharm Res, vol. 29, no. 3, pp. 806–17, Mar. 2012, doi: 10.1007/s11095-011-0605-4.
[16] I. C. Wang, M. J. Lee, S. J. Sim, W. S. Kim, N. H. Chun, and G. J. Choi, “Anti-solvent co-crystallization of carbamazepine and saccharin,” Int J Pharm, vol. 450, no. 1–2, pp. 311–322, Jun. 2013, doi: 10.1016/j.ijpharm.2013.04.012.
[17] F. Alatas et al., “Kelarutan dan Aktivitas Antimalaria Ko-Kristal Pirimetamin-Ibuprofen Solubility and Antimalarial Activity of Pyrimethamin-Ibuprofen Co-Crystal,” 2020.
[18] F. Darusman, S. N. Soewandhi, and R. Mauludin, “Peningkatan Kelarutan Dan Laju Disolusi Glimeripid Melalui Metode Kokristalisasi,” Jurnal Farmasi Galenika, vol. 3, no. 2, pp. 47–54, 2016.
